Patent 7514259 was granted and assigned to Schepens Eye Research Institute Inc. on April, 2009 by the United States Patent and Trademark Office.
The present invention relates to the isolation, in vitro propagation, and transplantation and integration of non-pigmented retinal stem cells derived from the neuroretina of the eye, ex vivo and in vivo.